Cargando…
Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
BACKGROUND: Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE) has not been sufficiently studied. METHODS: In this prospective observational...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492183/ https://www.ncbi.nlm.nih.gov/pubmed/28662657 http://dx.doi.org/10.1186/s12890-017-0440-4 |
_version_ | 1783247275329323008 |
---|---|
author | Grosse-Onnebrink, Joerg Stehling, Florian Tschiedel, Eva Olivier, Margarete Mellies, Uwe Schmidt, Rene Buer, Jan Rath, Peter-Micheal Steinmann, Joerg |
author_facet | Grosse-Onnebrink, Joerg Stehling, Florian Tschiedel, Eva Olivier, Margarete Mellies, Uwe Schmidt, Rene Buer, Jan Rath, Peter-Micheal Steinmann, Joerg |
author_sort | Grosse-Onnebrink, Joerg |
collection | PubMed |
description | BACKGROUND: Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE) has not been sufficiently studied. METHODS: In this prospective observational study, blood from CF patients experiencing FPE was tested with SF and BC before the initiation of antibiotic treatment. RESULTS: After contaminants had been excluded, 9 of 72 blood samples tested positive by BC or SF. SF exclusively detected four pathogens; BC, one. Pulmonary pathogen transmission was likely in all cases except for 2 cases of candidaemia, which were believed to be caused by catheter-related infections. For three cases, test results caused us to change the antibiotic regimen. Sensitivity (85.7% vs. 42.9%) and negative predictive value (98.4% vs. 87.0%) tended to be higher for SF than for BC. CONCLUSIONS: The results of SF and BC show that bacteraemia and fungaemia are present in CF patients during FPE and may affect antibiotic therapy. SF can help rule out catheter-related bloodstream infections. |
format | Online Article Text |
id | pubmed-5492183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54921832017-06-30 Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study Grosse-Onnebrink, Joerg Stehling, Florian Tschiedel, Eva Olivier, Margarete Mellies, Uwe Schmidt, Rene Buer, Jan Rath, Peter-Micheal Steinmann, Joerg BMC Pulm Med Research Article BACKGROUND: Bloodstream pathogens can be identified by multiplex PCR (SeptiFast (SF)) or blood culture (BC); whether these pathogens are present in cystic fibrosis (CF) patients during febrile pulmonary exacerbations (FPE) has not been sufficiently studied. METHODS: In this prospective observational study, blood from CF patients experiencing FPE was tested with SF and BC before the initiation of antibiotic treatment. RESULTS: After contaminants had been excluded, 9 of 72 blood samples tested positive by BC or SF. SF exclusively detected four pathogens; BC, one. Pulmonary pathogen transmission was likely in all cases except for 2 cases of candidaemia, which were believed to be caused by catheter-related infections. For three cases, test results caused us to change the antibiotic regimen. Sensitivity (85.7% vs. 42.9%) and negative predictive value (98.4% vs. 87.0%) tended to be higher for SF than for BC. CONCLUSIONS: The results of SF and BC show that bacteraemia and fungaemia are present in CF patients during FPE and may affect antibiotic therapy. SF can help rule out catheter-related bloodstream infections. BioMed Central 2017-06-29 /pmc/articles/PMC5492183/ /pubmed/28662657 http://dx.doi.org/10.1186/s12890-017-0440-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Grosse-Onnebrink, Joerg Stehling, Florian Tschiedel, Eva Olivier, Margarete Mellies, Uwe Schmidt, Rene Buer, Jan Rath, Peter-Micheal Steinmann, Joerg Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
title | Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
title_full | Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
title_fullStr | Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
title_full_unstemmed | Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
title_short | Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
title_sort | bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492183/ https://www.ncbi.nlm.nih.gov/pubmed/28662657 http://dx.doi.org/10.1186/s12890-017-0440-4 |
work_keys_str_mv | AT grosseonnebrinkjoerg bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT stehlingflorian bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT tschiedeleva bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT oliviermargarete bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT melliesuwe bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT schmidtrene bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT buerjan bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT rathpetermicheal bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy AT steinmannjoerg bacteraemiaandfungaemiaincysticfibrosispatientswithfebrilepulmonaryexacerbationaprospectiveobservationalstudy |